Xencor Inc. – Filings and Transcripts

NASDAQ: XNCR
Share price (11/6/26): $35.75
Market cap (11/6/26): $2.683 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Amendment to registration of securities for employees

Ownership Filter

Primecap Management

Zenas BioPharma Inc.

Vanguard Capital Management LLC

Vanguard Capital Management LLC

News Filter

Reports Third Quarter 2026 Financial Results

Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-In-Class ENPP3 X CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors

Reports Second Quarter 2026 Financial Results

To Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

SEC STAFF LETTER